BUMETANIDE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated with congestive heart failure, hepatic and renal disease. (Chemical Entities of Biological Interest Ontology, CHEBI_3213)
External Link https://dgidb.org/results?searchType=drug&searchTerms=BUMETANIDE
Similar Terms
Downloads & Tools

Genes

15 interacting proteins for the BUMETANIDE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
SLC17A3 solute carrier family 17 (organic anion transporter), member 3 6.6165
SLC12A4 solute carrier family 12 (potassium/chloride transporter), member 4 3.30825
SLC12A5 solute carrier family 12 (potassium/chloride transporter), member 5 2.2055
ADD1 adducin 1 (alpha) 1.65412
SLC12A2 solute carrier family 12 (sodium/potassium/chloride transporter), member 2 1.65412
SLC12A1 solute carrier family 12 (sodium/potassium/chloride transporter), member 1 1.03383
SCNN1G sodium channel, non voltage gated 1 gamma subunit 0.735167
GNB3 guanine nucleotide binding protein (G protein), beta polypeptide 3 0.551375
SLC12A3 solute carrier family 12 (sodium/chloride transporter), member 3 0.551375
GPR35 G protein-coupled receptor 35 0.150375
ACE angiotensin I converting enzyme 0.0987537
MAPK1 mitogen-activated protein kinase 1 0.0348237
KDM4E lysine (K)-specific demethylase 4E 0.0112525
HSD17B10 hydroxysteroid (17-beta) dehydrogenase 10 0.00797169
NFE2L2 nuclear factor, erythroid 2-like 2 0.00393371